This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovations of Gunnar Wrobel
Introduction
Gunnar Wrobel is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of preeclampsia. His work has implications for improving maternal health and understanding related disorders.
Latest Patents
Wrobel holds a patent titled "Use of ADAM 12 for diagnosis and therapy of preeclampsia." This invention highlights the important role of ADAM 12, ADAM 12-L, and ADAM 12-S in preeclampsia and related disorders. The patent discusses the use of these genes and their products, as well as ligands that bind to them, in the diagnosis and treatment of preeclampsia and associated syndromes. Furthermore, it explores the potential of additional genes and combinations for diagnosing these conditions.
Career Highlights
Gunnar Wrobel is affiliated with the Deutsches Krebsforschungszentrum, a leading cancer research center in Germany. His work at this institution has allowed him to focus on innovative research that bridges genetics and clinical applications. His dedication to advancing medical science is evident in his patent and ongoing research efforts.
Collaborations
Wrobel has collaborated with esteemed colleagues such as Peter Lichter and Marina Schorpp-Kistner. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Gunnar Wrobel's contributions to the field of preeclampsia research through his patent and collaborations underscore his commitment to advancing medical knowledge. His work has the potential to significantly improve diagnosis and treatment options for this serious condition.